CA2748809A1 - Precipitation of biomolecules with negatively charged polymers - Google Patents

Precipitation of biomolecules with negatively charged polymers Download PDF

Info

Publication number
CA2748809A1
CA2748809A1 CA2748809A CA2748809A CA2748809A1 CA 2748809 A1 CA2748809 A1 CA 2748809A1 CA 2748809 A CA2748809 A CA 2748809A CA 2748809 A CA2748809 A CA 2748809A CA 2748809 A1 CA2748809 A1 CA 2748809A1
Authority
CA
Canada
Prior art keywords
polymer
precipitate
biomolecule
antibody
paa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2748809A
Other languages
English (en)
French (fr)
Inventor
James Van Alstine
Jamil Shanagar
Rolf Hjorth
Karol Lacki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Global Life Sciences Solutions USA LLC
Original Assignee
GE Healthcare Bio Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Bio Sciences Corp filed Critical GE Healthcare Bio Sciences Corp
Publication of CA2748809A1 publication Critical patent/CA2748809A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/32—Extraction; Separation; Purification by precipitation as complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B01D15/327—Reversed phase with hydrophobic interaction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3847—Multimodal interactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
CA2748809A 2009-01-13 2010-01-11 Precipitation of biomolecules with negatively charged polymers Abandoned CA2748809A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0900032-4 2009-01-13
SE0900032 2009-01-13
PCT/SE2010/050017 WO2010082894A1 (en) 2009-01-13 2010-01-11 Precipitation of biomolecules with negatively charged polymers

Publications (1)

Publication Number Publication Date
CA2748809A1 true CA2748809A1 (en) 2010-07-22

Family

ID=42339999

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2748809A Abandoned CA2748809A1 (en) 2009-01-13 2010-01-11 Precipitation of biomolecules with negatively charged polymers

Country Status (7)

Country Link
US (1) US20120022239A1 (cg-RX-API-DMAC7.html)
EP (1) EP2376523A4 (cg-RX-API-DMAC7.html)
JP (1) JP2012515161A (cg-RX-API-DMAC7.html)
CN (1) CN102272146A (cg-RX-API-DMAC7.html)
AU (1) AU2010205007A1 (cg-RX-API-DMAC7.html)
CA (1) CA2748809A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010082894A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2902799B1 (fr) 2006-06-27 2012-10-26 Millipore Corp Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
US8569464B2 (en) 2006-12-21 2013-10-29 Emd Millipore Corporation Purification of proteins
US8163886B2 (en) 2006-12-21 2012-04-24 Emd Millipore Corporation Purification of proteins
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
US20120177610A1 (en) 2007-09-19 2012-07-12 Kieu Hoang Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
WO2009151514A1 (en) 2008-06-11 2009-12-17 Millipore Corporation Stirred tank bioreactor
DK2370561T3 (da) 2008-12-16 2019-10-21 Emd Millipore Corp Omrøringstankreaktor og fremgangsmåde
CN102892791B (zh) 2010-05-17 2017-05-17 Emd密理博公司 用于纯化生物分子的刺激响应性聚合物
WO2013021143A1 (fr) * 2011-08-10 2013-02-14 Adocia Solution injectable d'au moins une insuline basale
AU2012309202B2 (en) * 2011-09-16 2017-04-27 Cytiva Bioprocess R&D Ab Plasma protein fractionation by sequential polyacid precipitation
WO2013075740A1 (en) 2011-11-23 2013-05-30 Sanofi Antibody purification method
AR089231A1 (es) * 2011-12-15 2014-08-06 Amgen Inc Metodo de floculacion
TW201335181A (zh) * 2012-01-31 2013-09-01 Kieu Hoang 55種新發現的蛋白質之序列及其應用
CN103293299B (zh) * 2012-02-24 2016-06-08 珀金埃尔默医学诊断产品(上海)有限公司 拓宽双抗体夹心免疫检测浓度范围的方法及其试剂盒
DK2994485T3 (en) 2013-05-06 2018-04-23 Sanofi Sa CONTINUOUS MULTIPLE STEP PROCEDURE FOR PURIFICATION OF ANTIBODIES
CN105980846B (zh) 2014-02-21 2018-12-07 宝生物工程美国有限公司 包括聚(酸)膜分离基质的旋转柱及其制造和使用的方法
GB2539420B (en) * 2015-06-16 2021-01-13 Cytiva Sweden Ab Determination of chromatography conditions
EP3546475A1 (en) 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
CA3107770C (en) 2018-08-16 2023-09-05 Emd Millipore Corporation Closed bioprocessing device
CN114574457B (zh) * 2022-01-25 2024-07-23 华东理工大学 一种快速分离纯化蛋白质的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (cg-RX-API-DMAC7.html) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
US5976382A (en) * 1996-07-10 1999-11-02 Ligochem, Inc. Removal of proteins from aqueuos media by precipitation
DE102005003500A1 (de) * 2005-01-25 2006-07-27 Saint-Gobain Industriekeramik Rödental GmbH Brennguttragevorrichtung mit elastischer Stützenfixierung
US8362217B2 (en) * 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
RU2474585C2 (ru) * 2007-01-22 2013-02-10 Дженентек, Инк. Осаждение и очистка белков полиэлектролитами
WO2008100578A2 (en) * 2007-02-14 2008-08-21 Amgen Inc. Method of isolating antibodies by precipitation
WO2008156409A1 (en) * 2007-06-19 2008-12-24 Ge Healthcare Bio-Sciences Ab Separation method using polymer multi phase systems

Also Published As

Publication number Publication date
EP2376523A4 (en) 2012-11-28
CN102272146A (zh) 2011-12-07
US20120022239A1 (en) 2012-01-26
JP2012515161A (ja) 2012-07-05
EP2376523A1 (en) 2011-10-19
WO2010082894A1 (en) 2010-07-22
AU2010205007A1 (en) 2011-07-07

Similar Documents

Publication Publication Date Title
US20120022239A1 (en) Precipitation of biomolecules with negatively charged polymers
US9115181B2 (en) Separation method using single polymer phase systems
JP6471183B2 (ja) 生体分子の精製
TWI574975B (zh) 用於減少蛋白質純化期間樣本中一或多種雜質含量之方法
AU2012309202B2 (en) Plasma protein fractionation by sequential polyacid precipitation
JP4198751B2 (ja) 抗体の精製
US9695216B2 (en) Materials and methods for removing endotoxins from protein preparations
CN105008384A (zh) 在高电导率下在非离子性有机聚合物的存在下的蛋白质纯化
CN105008383A (zh) 在非离子有机聚合物和正电性表面存在下的蛋白质纯化
Van Alstine et al. Alternative separation methods: Flocculation and precipitation
Curbelo et al. Cost comparison of protein capture from cultivation broths by expanded and packed bed adsorption

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20150113